Home / Royal Mail / FTSE 250 movers: Indivior surges on FDA drug recommendation; Royal Mail weak again – DIGITALLOOK

FTSE 250 movers: Indivior surges on FDA drug recommendation; Royal Mail weak again – DIGITALLOOK


DIGITALLOOK

FTSE 250 movers: Indivior surges on FDA drug recommendation; Royal Mail weak again
DIGITALLOOK
On the downside, Royal Mail was in the red for the second day running after Credit Suisse downgraded the stock on Tuesday to 'underperform' from 'neutral'. The bank said it expects worsening letter revenue trends and a costly labour deal to render 2018 …

and more »

More: continued here

About admin

Check Also

Romanian political crisis delays Czech tycoon’s £3.6bn Royal Mail takeover

By DAILY MAIL CITY & FINANCE REPORTER Updated: 17:00 EST, 5 March 2025 Delays: Czech …

Leave a Reply

Your email address will not be published. Required fields are marked *